Health outcomes of sexual and gender minorities after cancer: a systematic review

ML Pratt-Chapman, AB Alpert, DA Castillo - Systematic reviews, 2021 - Springer
Purpose Cancer research on sexual and gender minority (SGM) populations is gaining
momentum. The purpose of this systematic review was to examine what is currently known …

Diagnosing sexual dysfunction in men and women: sexual history taking and the role of symptom scales and questionnaires

D Hatzichristou, PS Kirana, L Banner… - The journal of sexual …, 2016 - academic.oup.com
Introduction A detailed sexual history is the cornerstone for all sexual problem assessments
and sexual dysfunction diagnoses. Diagnostic evaluation is based on an in-depth sexual …

Evaluating SEM model fit with small degrees of freedom

D Shi, C DiStefano, A Maydeu-Olivares… - Multivariate behavioral …, 2022 - Taylor & Francis
Research has revealed that the performance of root mean square error of approximation
(RMSEA) in assessing structural equation models with small degrees of freedom (df) is …

Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation

K Hatzimouratidis, E Amar, I Eardley, F Giuliano… - European urology, 2010 - Elsevier
CONTEXT: Erectile dysfunction (ED) and premature ejaculation (PE) are the two most
prevalent male sexual dysfunctions. OBJECTIVE: To present the updated version of 2009 …

[HTML][HTML] Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study

J Sønksen, NJ Barber, MJ Speakman, R Berges… - European urology, 2015 - Elsevier
Background Transurethral resection of the prostate (TURP) is considered the gold standard
for male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia …

Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial

MJ Barry, S Meleth, JY Lee, KJ Kreder, AL Avins… - Jama, 2011 - jamanetwork.com
Context Saw palmetto fruit extracts are widely used for treating lower urinary tract symptoms
attributed to benign prostatic hyperplasia (BPH); however, recent clinical trials have …

[HTML][HTML] Alpha blockers for the treatment of benign prostatic hyperplasia

H Lepor - Reviews in urology, 2007 - ncbi.nlm.nih.gov
The evolution of alpha blocker therapy for benign prostatic hyperplasia (BPH) has focused
on improving convenience and tolerability. Indications for treating BPH include reversing …

Changes in sexual roles and quality of life for gay men after prostate cancer: challenges for sexual health providers

TL Hart, DW Coon, MA Kowalkowski… - The journal of sexual …, 2014 - academic.oup.com
Introduction Gay men with prostate cancer (GMPCa) may have differential health‐related
quality of life (HRQOL) and sexual health outcomes than heterosexual men with prostate …

Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia

PT Chin, DM Bolton, G Jack, P Rashid, J Thavaseelan… - Urology, 2012 - Elsevier
OBJECTIVE: To evaluate the effectiveness of the prostatic urethral lift in relieving lower
urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia. METHODS: A total …

Rezūm therapy for≥ 80‐mL benign prostatic enlargement: a large, multicentre cohort study

D Elterman, N Bhojani, C Vannabouathong… - BJU …, 2022 - Wiley Online Library
Objective To evaluate the efficacy and safety of Rezūm therapy in benign prostatic
hyperplasia (BPH) patients with prostates≥ 80 mL. Methods A prospective registry was …